daunorubicin has been researched along with isoxanthohumol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Hintzpeter, J; Martin, HJ; Maser, E; Seliger, JM | 1 |
2 other study(ies) available for daunorubicin and isoxanthohumol
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin.
Topics: Alcohol Oxidoreductases; Cell Line, Tumor; Chalcones; Daunorubicin; Flavanones; Flavonoids; Hexanones; Humans; Inhibitory Concentration 50; Kinetics; Oxidation-Reduction; Propiophenones; Recombinant Proteins; Substrate Specificity; Xanthones | 2019 |